Tradestie Institutional Equity Comparison Engine

IMCR vs DYN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IMCR Overall Edge

IMCR Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immunocore Holdings plc American Depositary Shares (IMCR) driven by superior Valuation, Options & Structure while DYN counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, IMCR trades at 20.8x Forward P/E with -2.2% operating margin (-1.4% YoY revenue) versus DYN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, IMCR sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro) against DYN sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner IMCR
IMCR 20.8x vs DYN N/M Fwd P/E
Growth & Margin Winner DYN
Op Margin -2.2% vs 0.0% ยท YoY -1.4% vs +0.0%
Momentum & Technical Winner DYN
1Y -31.7% vs -24.8% ยท 52W Pos 5% vs 11%
Options & Structure Winner IMCR
UNCLASSIFIED (10th %ile IV) vs BREAKDOWN (9th %ile IV)
IMCR NASDAQ
Immunocore Holdings plc American Depositary Shares
Biological Products, (No Disgnostic Substances)
$26.41
-0.83% 1D
Market Cap $1.4B
1M Return -17.78%
1Y Return -31.67%
Forward P/E 20.8x
Unified AI Score
44.1 / 100 HOLD
Tech 33.0 Fund 47.0 Flow 50.0 Mom 64.0
DYN NASDAQ
Dyne Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$15.50
-3.31% 1D
Market Cap $3.0B
1M Return -1.71%
1Y Return -24.76%
Forward P/E N/M
Unified AI Score
39.9 / 100 SELL
Tech 25.0 Fund 48.0 Flow 70.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMCR -31.67% DYN -24.76% Spread: +6.91 pp (DYN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IMCR TTM Op. Margin: -2.2% DYN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMCR vs DYN. Trailing 12-month operating profitability (IMCR -2.2% vs DYN 0.0%) and valuation multiples (IMCR 20.8x vs DYN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMCR (5) vs DYN (5)
Institutional Metric IMCR DYN Criterion Row Winner
Market Capitalization Scale $1.4B $3.0B Larger Scale DYN
Trailing P/E Ratio Valuation 20.8x N/M Lower Multiple IMCR
Forward P/E Ratio Valuation 20.8x N/M Lower Multiple IMCR
Revenue Growth (YoY) Growth -1.4% +0.0% Higher Growth DYN
Operating Margin (TTM) Profitability -2.2% 0.0% Higher Margin DYN
Net Profit Margin Profitability -7.5% 0.0% Higher Margin DYN
Return on Equity (ROE) Capital Efficiency -7.9% -74.6% Higher ROE IMCR
52-Week Range Position Momentum 5% ($26โ€“$41) 11% ($14โ€“$27) Stronger Trend DYN
Beta / 30D Volatility Risk Regime 0.63ฮฒ ยท 49% Vol 1.55ฮฒ ยท 55% Vol Lower Realized Risk IMCR
Unified Institutional Score Composite Signal 44.1 / 100 (HOLD) 39.9 / 100 (SELL) Higher Composite IMCR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMCR vs DYN Buy Guide
IMCR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live IMCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DYN BREAKDOWN
72d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live DYN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMCR nor DYN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.